Skip to main content
CGON
NASDAQ Life Sciences

Q3 Net Loss Widens to $56.9M as PIVOT-006 Topline Data Nears This Month

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$64.8
Mkt Cap
$5.744B
52W Low
$35.8
52W High
$80.97
52W Position info
81% above low
Off High info
20% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

CGON sits 81% above its 52-week low of $35.8.

Summary

CG Oncology posted a Q3 2026 net loss of $56.9 million, or $0.64 per share, wider than the $43.8 million loss a year ago, driven by R&D expenses climbing to $39.2 million from $27.9 million on higher clinical trial and CMC costs. Cash and marketable securities stood at $984.5 million as of September 30, down modestly from $1.0 billion at June 30, with the company guiding that this funds operations through 2029. The real driver for the stock is the pipeline calendar: PIVOT-006 Phase 3 topline data in intermediate-risk and high-grade Ta NMIBC is due this month, with 12-month data from CORE-008 Cohort CX and BOND-003 Cohort P in December and completion of the BLA submission in BCG-unresponsive NMIBC with CIS targeted for Q4 2026. The company also named Isabel Kalofonos as Chief Commercial Officer in October, a hire pointing toward launch preparation. The financials are largely secondary here; the PIVOT-006 readout this month is the binary event that will set the stock's direction.

At the time of this announcement, CGON was trading at $64.80 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.7B. The 52-week trading range was $35.80 to $80.97. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

CGON - Latest Insights

CGON
Nov 18, 2026, 4:30 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $79.68
Real-time Price: $79.50 info
Change: -$0.180 (-0.23%) info
Market Cap: $7.098B info
CGON
Nov 16, 2026, 8:15 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $99.10
Real-time Price: $79.50 info
Change: -$19.60 (-20%) info
Market Cap: $7.098B info
CGON
Nov 16, 2026, 8:00 AM EST
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $100.01
Real-time Price: $79.50 info
Change: -$20.51 (-21%) info
Market Cap: $7.098B info
CGON
Aug 07, 2026, 4:39 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $75.10
Real-time Price: $79.50 info
Change: +$4.40 (+6%) info
Market Cap: $7.098B info
CGON
Aug 06, 2026, 8:45 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $71.51
Real-time Price: $79.50 info
Change: +$7.99 (+11%) info
Market Cap: $7.098B info